PRLog - July 3, 2014 - MUMBAI, India -- Transasia Bio-Medicals Ltd. for over 35 years, is recognized for providing the latest technological advances and encouraging knowledge sharing among experts as a part of its commitment to healthcare.
dr bhide & dr. kulkarni with award
It played an active part in the recently concluded First Annual Conference of Association of Practicing Pathologists (APPI) of India held on 14-15 June'14 at Mumbai. The APPI was a confluence of expertise, offering an excellent platform for knowledge sharing.
A poster presentation competition was one of the highlights of the conference, offering insights on daily laboratory experiences. The poster that won the first prize was presented by Dr. Harshala Kulkarni from Dr Bhide’s Laboratory under the guidance of Dr. Milind Bhide and his expert team comprising Dr. Harshala Kulkarni, Dr. M G Bhide and Mrs. Deepali Suryavanshi. The poster on 'Slide Review Criteria on the Sysmex XN-1000 in a Private Laboratory in Mumbai' highlighted the use of Sysmex XN-1000 analyzer (an advanced cell counter) with middleware for seamless automation. Sysmex XN 1000- 6 PDA hematology analyzer is marketed in India through Transasia Bio-Medicals Ltd.
The poster presentation highlighted the following aspects about Sysmex XN-1000:
•It offers several new parameters such as immature granulocytes, NRBCs and Ret-He
•It has advanced capabilities for data handling
•Transmits more than 200 parameters to the host PC for every sample
•New features of XN 1000, the Q flags generated by the system and slide review criteria using these feature when incorporated into the middleware successfully brought down the slide review rate to 18.7% with the sensitivity of 81.24% and specificity of 99.89%
Along with APPI, Transasia was also proud to exclusively arrange a panel discussion on 'Issues in Hematology' by :
· Dr. Joy Mammen, Prof. & Head-Dept. Of Transfusion Medicine & Immuno
Hematology, CMC Vellore,
·Dr. Anil Handoo, Sr. Consultant & Director Pathology-BLK Super Speciality Hospital,
New Delhi and
·Dr. Kunal Sehgal, Consulting Hematologist-
The panel discussion was moderated by Dr. Anita Karnik, Director-Dr. Karnik Pathology Laboratory.
Eminent pathologists and hematologists from different parts of the region attended the session and gathered expert opinion on the challenges they face in day-to-day operations.
About Transasia Bio-Medicals Ltd. - Incepted in the year 1979, Transasia Bio-Medicals Ltd., is headquartered in Mumbai, India. It is one of India’s largest In-vitro Diagnostics Company and offers solutions and products in Biochemistry, Hematology, Coagulation, ESR, Immunology, Urinalysis, Critical Care, Electrophoresis, Molecular Diagnostics, Diabetes Management and Microbiology. Infact, Transasia is the first Indian company to manufacture and export sophisticated, state of the art blood analyzers and reagents.
Transasia is a part of the global ERBA Diagnostics Mannheim GmbH Group. The ERBA Group has spread its footprint across USA, Europe, Turkey and Eastern Europe, Russia and France, by means of various acquisitions – ERBA Lachema s.r.o.(Czech Republic), ERBA Russia (Russia), ERBA Diagnostics, Inc. (USA), Diamedix Corporation (USA), Delta Biologicals,S.r.l (Italy), ImmunoVision, Inc. (USA), Erba DDS (Turkey), ERBA Diagnostics France (France), JAS Diagnostics Inc. (USA) and Drew Scientific (USA).
Transasia manufactures and markets equipment and reagents, with an impressive install base of around 38,000 equipments across India. Transasia also exports to more than 94 countries in five continents.
The vast network of more than 150 service engineers, 350+ Sales and Marketing Team, 14 zonal offices, and 300+ Distributors allows us to reach out to customers across the length and breadth of the country.
Alliances with international partners like Sysmex Corporation(
With a vision of being recognized as a ‘local for global’ organization, Transasia continues to provide doctors and patients with reliable, affordable and innovative Medical Diagnostic Systems.